(19)
(11)
EP 0 661 996 A1
(12)
(43)
Date of publication:
12.07.1995
Bulletin 1995/28
(21)
Application number:
93900577.0
(22)
Date of filing:
18.11.1992
(51)
International Patent Classification (IPC):
A61K
38/
00
( . )
A61K
39/
00
( . )
A61K
47/
48
( . )
A61P
37/
00
( . )
C07K
14/
47
( . )
C07K
14/
74
( . )
G01N
33/
564
( . )
A61K
31/
70
( . )
A61K
39/
385
( . )
A61P
29/
00
( . )
C07K
1/
113
( . )
C07K
14/
705
( . )
G01N
33/
53
( . )
(86)
International application number:
PCT/US1992/010031
(87)
International publication number:
WO 1993/009810
(
27.05.1993
Gazette 1993/13)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
(30)
Priority:
19.11.1991
US 19910793938
(71)
Applicant:
ANERGEN, INC.
Redwood City, CA 94063 (US)
(72)
Inventors:
NAG, Bishwajit
Pacifica, CA 94044 (US)
CLARK, Brian, R.
Redwood City, CA 94061 (US)
SHARMA, Somesh, D.
Os Altos, CA 94022 (US)
MCCONNEL, Harden, M.
Stanford, CA 94305 (US)
(74)
Representative:
Armitage, Ian Michael, et al
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)
(54)
MHC SUBUNIT CONJUGATES USEFUL IN AMELIORATING DELETERIOUS IMMUNE RESPONSES